These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31773691)

  • 1. A meta-analysis of influence of MSMB promoter rs10993994 polymorphisms on prostate cancer risk.
    Fu S; Huang YL; Luan T; Li N; Wang HF; Wang JS
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9295-9303. PubMed ID: 31773691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MSMB gene rs10993994 polymorphism increases the risk of prostate cancer.
    Peng T; Zhang L; Zhu L; Mi YY
    Oncotarget; 2017 Apr; 8(17):28494-28501. PubMed ID: 28212531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MSMB gene variant alters the association between prostate cancer and number of sexual partners.
    Stott-Miller M; Wright JL; Stanford JL
    Prostate; 2013 Dec; 73(16):1803-9. PubMed ID: 24037734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
    Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
    Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.
    Whitaker HC; Kote-Jarai Z; Ross-Adams H; Warren AY; Burge J; George A; Bancroft E; Jhavar S; Leongamornlert D; Tymrakiewicz M; Saunders E; Page E; Mitra A; Mitchell G; Lindeman GJ; Evans DG; Blanco I; Mercer C; Rubinstein WS; Clowes V; Douglas F; Hodgson S; Walker L; Donaldson A; Izatt L; Dorkins H; Male A; Tucker K; Stapleton A; Lam J; Kirk J; Lilja H; Easton D; ; ; ; Cooper C; Eeles R; Neal DE
    PLoS One; 2010 Oct; 5(10):e13363. PubMed ID: 20967219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.
    Lou H; Yeager M; Li H; Bosquet JG; Hayes RB; Orr N; Yu K; Hutchinson A; Jacobs KB; Kraft P; Wacholder S; Chatterjee N; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Ma J; Gaziano JM; Stampfer M; Schumacher FR; Giovannucci E; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Anderson SK; Tucker M; Hoover RN; Fraumeni JF; Thomas G; Hunter DJ; Dean M; Chanock SJ
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7933-8. PubMed ID: 19383797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression.
    Xu B; Wang J; Tong N; Mi Y; Min Z; Tao J; Li P; Cheng G; Li J; Wang M; Tang J; Song N; Zhang Z; Zhang W; Wu H; Hua L; Feng N
    Prostate; 2010 Jul; 70(10):1146-52. PubMed ID: 20333697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk.
    Chang BL; Cramer SD; Wiklund F; Isaacs SD; Stevens VL; Sun J; Smith S; Pruett K; Romero LM; Wiley KE; Kim ST; Zhu Y; Zhang Z; Hsu FC; Turner AR; Adolfsson J; Liu W; Kim JW; Duggan D; Carpten J; Zheng SL; Rodriguez C; Isaacs WB; Grönberg H; Xu J
    Hum Mol Genet; 2009 Apr; 18(7):1368-75. PubMed ID: 19153072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.
    Xu X; Valtonen-André C; Sävblom C; Halldén C; Lilja H; Klein RJ
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2035-42. PubMed ID: 20696662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of prostate cancer susceptibility variant (MSMB) rs10993994 with risk of spermatogenic failure.
    Wu W; Lu J; Yuan B; Qin Y; Chen M; Niu X; Xu B; Lu C; Xia Y; Chen D; Sha J; Wang X
    Gene; 2013 Jul; 524(2):197-202. PubMed ID: 23608167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer.
    Yeager M; Deng Z; Boland J; Matthews C; Bacior J; Lonsberry V; Hutchinson A; Burdett LA; Qi L; Jacobs KB; Gonzalez-Bosquet J; Berndt SI; Hayes RB; Hoover RN; Thomas G; Hunter DJ; Dean M; Chanock SJ
    Hum Genet; 2009 Dec; 126(6):743-50. PubMed ID: 19644707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.
    FitzGerald LM; Zhang X; Kolb S; Kwon EM; Liew YC; Hurtado-Coll A; Knudsen BS; Ostrander EA; Stanford JL
    Hum Mutat; 2013 Jan; 34(1):149-56. PubMed ID: 22887727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB.
    Bicak M; Wang X; Gao X; Xu X; Väänänen RM; Taimen P; Lilja H; Pettersson K; Klein RJ
    Hum Mol Genet; 2020 Jun; 29(10):1581-1591. PubMed ID: 32065238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
    Waters KM; Stram DO; Le Marchand L; Klein RJ; Valtonen-André C; Peltola MT; Kolonel LN; Henderson BE; Lilja H; Haiman CA
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2639-46. PubMed ID: 20736317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
    Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
    Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the MSMB gene in familial prostate cancer.
    Kote-Jarai Z; Leongamornlert D; Tymrakiewicz M; Field H; Guy M; Al Olama AA; Morrison J; O'Brien L; Wilkinson R; Hall A; Sawyer E; Muir K; Hamdy F; Donovan J; Neal D; Easton D; Eeles R
    Br J Cancer; 2010 Jan; 102(2):414-8. PubMed ID: 19997100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RTK/ERK pathway is associated with prostate cancer risk on the SNP level: a pooled analysis of 41 sets of data from case-control studies.
    Chen Y; Li T; Yu X; Xu J; Li J; Luo D; Mo Z; Hu Y
    Gene; 2014 Jan; 534(2):286-97. PubMed ID: 24177231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter Polymorphism (rs12770170, -184C/T) of Microseminoprotein, Beta as a Risk Factor for Benign Prostatic Hyperplasia in Korean Population.
    Ban JY; Yoo KH
    Int Neurourol J; 2014 Jun; 18(2):63-7. PubMed ID: 24987558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis.
    Zhang H; Li L; Xu Y
    PLoS One; 2013; 8(7):e68634. PubMed ID: 23861929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between APE1 rs1760944 and rs1130409 polymorphism with prostate cancer risk: A systematic review and meta-analysis.
    Liu J; Zheng J; Guo Y; Sheng X; Yin Y; Qian S; Xu B; Xiong W; Yin X
    Medicine (Baltimore); 2021 Nov; 100(46):e27630. PubMed ID: 34797286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.